Prostatis Group’s Schwab US Large- Cap ETF SCHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Buy
8,444
+331
+4% +$9.45K 0.06% 159
2026
Q1
$208K Hold
8,113
0.05% 162
2025
Q4
$218K Hold
8,113
0.05% 159
2025
Q3
$214K Buy
+8,113
New +$206K 0.05% 161
2024
Q4
Sell
-9,582
Closed -$217K 158
2024
Q3
$217K Buy
+9,582
New +$209K 0.07% 127

Other funds holding SCHX

Prostatis Group's SCHX Position: Q2 2026 in Review

Prostatis Group increased its Schwab US Large- Cap ETF (SCHX) stake by 4.1% in Q2 2026, buying an estimated $9.45K and bringing the position to 8,444 shares worth $249K. The position accounts for 0.06% of the portfolio, ranked #159.

Prostatis Group first reported a position in SCHX in Q3 2024 and has held it in 5 quarters since. 1,594 funds tracked by Wall St. Rank hold SCHX as of Q2 2026.

  • Prostatis Group held 8,444 shares of Schwab US Large- Cap ETF worth $249K as of Q2 2026.
  • Prostatis Group bought 331 Schwab US Large- Cap ETF shares in Q2 2026, an estimated $9.45K.
  • Schwab US Large- Cap ETF made up 0.06% of Prostatis Group's portfolio in Q2 2026, its #159 holding.
  • Prostatis Group first reported a position in Schwab US Large- Cap ETF in Q3 2024 and has held it in 5 quarters since.
  • 1,594 funds tracked by Wall St. Rank held Schwab US Large- Cap ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.